id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-5739-0002,FDA,FDA-2017-D-5739,Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA Guidance for Industry; Draft Guidance,Other,Guidance,2017-10-03T04:00:00Z,2017,10,2017-10-03T04:00:00Z,2017-12-05T04:59:59Z,2022-10-05T19:11:18Z,,0,0,0900006482b94e1d
FDA-2017-D-5739-0001,FDA,FDA-2017-D-5739,"Formal Meetings Between the Food and Drug Administration and
Abbreviated New Drug Application Applicants of Complex Products Under Generic Drug User Fee Act; Draft Guidance for Industry;  Availability",Notice,Notice of Availability,2017-10-03T04:00:00Z,2017,10,2017-10-03T04:00:00Z,2017-12-05T04:59:59Z,2017-12-05T02:01:48Z,2017-21190,0,0,0900006482b9370d